The
surgical site infection market is growing on account of a rise in the
volume of surgeries and resulting infections, growing geriatric population, and
advancements in technology. The domain size, which was $4.0 billion in 2017, is
expected to grow to $5.9 billion by 2023 at a CAGR of 6.4% during 2018–2023
(forecast period). By definition, the market includes all the equipment and
procedures used to prevent or treat surgical infections. On the basis of phase,
the market can be divided into preoperative, intraoperative, and postoperative.
Now, one of the primary
reasons the volume of surgeries is growing is the increase in geriatric
population. As the elderly are more prone to diseases requiring surgical intervention,
a rise in their population will automatically propel the number of surgeries
performed. Further, aged people are also more susceptible to infections on
account of their low immunity, which is why such people would be another
primary growth driver of the surgical site infection market during the forecast
period.
Therefore, it is clear that
the growth in geriatric population will result in an increase in the number of
surgeries, which will further the market for SSI across the world.
Across
the globe, the domain is advancing due to the growing volume of surgeries and
rising incidents of SSIs. According to the World Bank, 30,537 surgeries were
done per 100,000 people in the U.S. in 2012, while the number for Australia
stood at 28,907 per 100,000 people. Now, a lot of surgeries, even though all
preventive measures are taken, result in infections. As per the European Centre
for Disease Prevention and Control, between 2013 and 2014, of the 967,191
surgeries performed in Europe, 18,364 resulted in infections. Thus, with the
growing number of surgeries in the future, the incidents of infection will also
increase, taking the SSI market forward.
 |
| To Learn more about this report: http://bit.ly/2o3oONH |
Globally,
North America contributed the highest revenue share (38.4%) to the domain in
2017, owing to a growing awareness about SSIs, presence of a large number of
SSI product manufacturers, and developed healthcare infrastructure. While the
continent will still lead the SSI market during the forecast period,
Asia-Pacific will witness the fastest growth, at a 7.7% CAGR. This can be
attributed to the increase in geriatric population, improvements in healthcare
infrastructure, rising incidents of such infections, and penetration of
advanced products for SSI prevention and management.
